Toxic Levels of Thymoquinone in Black Seed Oil
Based on available evidence, thymoquinone (TQ) appears to have a very low toxicity profile with no established toxic threshold in humans, though doses up to 48.6 mg/day appear safe for adults, and clinical trials using 200 mg of TQ-rich black seed oil (containing approximately 10 mg TQ) daily for 90 days showed no serious adverse effects 1.
Understanding the Safety Profile
The evidence regarding TQ toxicity is limited but reassuring:
Established Safe Dosing Range
Clinical trial data: A phase 1 randomized controlled trial evaluated black cumin oil containing 5% TQ (BCO-5) at 200 mg/adult/day for 90 days and found no serious adverse effects or significant alterations in hematological or biochemical parameters related to liver function (ALT, AST, ALP) or renal function (serum creatinine and urea) 1.
Suggested safe upper limit: Based on literature review, a safe daily TQ dosage appears to be less than 48.6 mg per adult 2. A dose of 4 mL of high-quality black seed oil per day contains approximately 30 mg TQ, which is considered unlikely to be harmful 2.
Toxicity Characteristics
The general toxicology framework defines toxicity as the presence of clinical signs or symptoms compatible with toxicity, with diagnosis most frequently based on blood levels 3. However, for TQ specifically:
- Multiple studies characterize N. sativa seeds and TQ as having a "very low degree of toxicity" 4
- Only two cases of contact dermatitis have been reported following topical use 4
- No significant adverse effects on liver or kidney function have been documented with seed extract or oil administration 4
Reported Side Effects
The side effects documented are generally mild:
- Gastrointestinal: Minor symptoms including nausea, though not serious 5
- Dermatological: Rare contact dermatitis with topical application 4
- No serious systemic toxicity has been reported in clinical studies 1, 5
Critical Caveats
Product Quality Variability
A major concern is the extreme variability in TQ content across commercial products. Analysis of commercial black seed oils and capsules showed TQ content ranging from 3.08 to 809.4 mg/100 g 2. This inconsistency means:
- Consumers cannot reliably know their TQ intake from unregulated products
- Products should be regulated regarding TQ content to enable safe consumption 2
- High-quality products with verified TQ content are essential for safety
Lack of Established Upper Limits
Unlike micronutrients that have defined Tolerable Upper Intake Levels (UL) 3, no formal UL has been established for TQ. The framework for determining toxicity would require:
- Blood concentrations higher than upper reference values (overdose) 3
- Clinical signs or symptoms compatible with toxicity 3
Neither has been systematically established for TQ in humans.
Special Populations
While general safety appears good, specific data for vulnerable populations (pregnancy, children, patients with hepatic or renal disease) is limited. The general principle that patients with diseases reducing elimination are at higher risk for overdose 3 would theoretically apply to TQ, though specific evidence is lacking.
Practical Recommendations
For clinical use, limit TQ intake to less than 48.6 mg/day in adults, preferably using products with verified TQ content 2. When using black seed oil products:
- Choose products with documented TQ content analysis
- Start with conservative doses (e.g., 4 mL oil containing ~30 mg TQ daily)
- Monitor for gastrointestinal symptoms
- Avoid in patients with known contact sensitivity
The absence of serious toxicity in clinical trials up to 90 days suggests short-to-medium term use at recommended doses is safe 1, but long-term safety data beyond this timeframe remains limited.